Skip to content

Marcyrl

Pharma·Egypt·Active·3yr hold
Entry
2023
Hold
3yr
Status
Active

Who owns Marcyrl?

Marcyrl is currently owned by Edmond de Rothschild Private Equity (France) through Amethis Fund III (2023 vintage), since 2023. Across its history, Marcyrl has been through 2 private equity ownership periods, detailed in the timeline below.

Hand-verified · updated 2026-04-21

Edmond de Rothschild Private Equity (France)
Most recent investor
Edmond de Rothschild Private Equity (France)
Amethis Fund III · 2023 · Growth
2 ownership periods · full history below

Key facts

HQEgypt
SectorPharma

Ownership history

2 ownership periods · co-invest detected

Active
Co-invest · 2 holders · 2023 · present
Amethis
AmethisActive
2023 · present(3yr) · Amethis MENA Fund II · 2022 · Growth
Edmond de Rothschild Private Equity (France)
2023 · present(3yr) · Amethis Fund III · 2023 · Growth
Track Marcyrl

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Marcyrl?

7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Marcyrl.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue